molecular virology
| 4 min read
Two reports landed the same week: one documenting rising pandemic risk, the other showing how little of the antiviral pipeline is ready to meet it. Then Ebola was declared a public health emergency.
| 2 min read
New study uses simulations and machine learning to identify a single, high-impact interaction within a viral fusion protein, highlighting a potential new target for antiviral drug development.
| 6 min read
Experts discussed the major hurdles of AAV gene therapy, including immunogenicity, vector design, and AAV variability.
Page 1 of 1 - 3 Total Items
